SCHEMBL2903058

SCHEMBL2903058

COc1ccc(Oc2cc[c]cn2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.44
ALDH1A1 P00352 2/20 0.44
KMT2A Q03164 2/20 0.44
NPC1 O15118 1/20 0.44
HTT P42858 1/20 0.44
RAB9A P51151 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
HAO1 Q9UJM8 1/20 0.43
L3MBTL1 Q9Y468 3/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
LTA4H P09960 2/20 0.41
MAP4K4 O95819 1/20 0.39
LMNA P02545 1/20 0.37
MAPT P10636 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2752900 0.87 ALDH1A1 (0.41) MEN1ALDH1A1KMT2ANPC1HTT
SCHEMBL2894972 0.85 MEN1 (0.52) MEN1ALDH1A1KMT2ANPC1HTT
SCHEMBL7953772 0.83 ALDH1A1 (0.55) MEN1ALDH1A1KMT2ANPC1RAB9A
SCHEMBL2752841 0.82 CA2 (0.47) MEN1ALDH1A1KMT2AHTTL3MBTL1
SCHEMBL2899323 0.81 MAPT (0.39) MEN1ALDH1A1KMT2AHTTLTA4H
SCHEMBL1712271 0.81 MEN1 (0.50) MEN1ALDH1A1KMT2AHTTL3MBTL1
SCHEMBL2901814 0.81 L3MBTL1 (0.44) MEN1ALDH1A1KMT2ANPC1HTT
SCHEMBL315475 0.81 ALDH1A1 (0.43) MEN1ALDH1A1KMT2ANPC1HTT
SCHEMBL2901946 0.81 RAB9A (0.54) MEN1ALDH1A1KMT2ANPC1HTT
SCHEMBL2894886 0.81 HRH3 (0.38) MEN1ALDH1A1KMT2AHTTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106146518-A A kind of bruton's tyrosine kinase inhibitor intermediate and preparation method thereof 苏州爱玛特生物科技有限公司 2016-11-23 CN disclosed
US-20100305124-A1 Acylated Aminopyridine and Aminopyridazine Insecticides BAYER CROPSCIENCE AG (DE) 2010-12-02 US disclosed
EP-2236505-A1 Acylated aminopyridines and pyridazines as insecticides Bayer CropScience AG (DE) 2010-10-06 EP disclosed
US-4954497-A AGRICULTURE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1990-09-04 US disclosed
EP-0330939-A2 Acrylic acid morpholides, their production and use Takeda Chemical Industries, Ltd. (JP) 1989-09-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305124-A1 Acylated Aminopyridine and Aminopyridazine Insecticides AAAS, DDT, QDPR MEN1 2671/4885ALDH1A1 551/4885KMT2A 412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.